FDA-mandated studies indicate higher than expected levels of contamination on duodenoscopes after reprocessing.
The move comes about a week after the San Diego-based company revealed it would cut 50% of its workforce.
Solana Beach, CA-based Puregraft has developed a technology that would use a person’s own fat for breast augmentation or restructuring.
The Rolling Stones frontman’s recent procedure has brought a great deal of awareness to the TAVR market, which could be beneficial to device makers in the space.
FDA warns the public not to use devices or apps marketed to consumers that claim to help assess, diagnose, or manage head injuries.
The Palo Alto, CA-based company has received FDA clearance for a wearable that can remotely monitor patients with chronic diseases, such as chronic obstructive pulmonary disease (COPD), allowing the detection of early signs of deterioration before symptoms are noticeable.
A fast-growing company known for its virtual reality surgical training program has expanded into the European market.
Alcon performed extremely well on the market trading at $57.81 a share, giving the eye-care company a value of nearly $29 billion.
The company said that it will integrate its Edison platform with the American College of Radiology, Artificial Intelligence-Lab.
A cervical interbody spacer’s roughened porous surfaces and other unique features effectively engage bone and promote healing.
Researchers from Emory University presented results from the study at the American Physiological Society’s annual meeting at Experimental Biology 2019 in Orlando, Fla.
The Galway, Ireland-based company’s technology is a minimally invasive approach toward treating anal fistula.
France banned several types of textured breast implants Friday as a precautionary measure. The implants are suspected of causing a rare form of cancer.